Susquehanna Fundamental Investments’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,218	Closed	-$324K	–	1596
2022 Q3	$324K	Buy	+16,218	New	+$214K	0.01%	1137
2022 Q1	$533K	Hold	57,275	–	–	0.01%	1054
2021 Q4	$814K	Buy	57,275 +19,628	+52%	+$340K	0.02%	730
2021 Q3	$873K	Buy	37,647 +24,492	+186%	+$579K	0.02%	925
2021 Q2	$327K	Buy	+13,155	New	+$353K	0.01%	1335
2021 Q1	–	Sell	-6,695	Closed	-$234K	–	1660
2020 Q4	$234K	Sell	6,695 -16,662	-71%	-$725K	﹤0.01%	1330
2020 Q3	$1.16M	Buy	+23,357	New	+$944K	0.03%	587

Susquehanna Fundamental Investments's FMTX Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 16,218 shares — an estimated $324K sold.

Susquehanna Fundamental Investments first reported a position in FMTX in Q3 2020 and held it in 7 quarters. The position peaked at $1.16M in Q3 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Susquehanna Fundamental Investments reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 16,218 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $324K.
Susquehanna Fundamental Investments first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Susquehanna Fundamental Investments's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.16M in Q3 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.